Bedaquiline Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Alerts
• Clinical Trials

Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy (Phase 2)
Condition:   Leprosy Interventions:   Drug: BE-PEP (Bedaquiline);   Drug: SDR-PEP;   Drug: BE-PEP (Rifampicine) Sponsors:   Institute of Tropical Medicine, Belgium;   Damien Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 6, 2022 Category: Research Source Type: clinical trials

Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in Combination With Delamanid or Bedaquiline, Delamanid in Combination With Bedaquiline, or Standard of Care in Male and Female Participants Aged 18 to 65 Years With Pulmonary Tuberculosis
Condition:   Tuberculosis Interventions:   Drug: GSK3036656;   Drug: Bedaquiline;   Drug: Delamanid;   Drug: RIFAFOUR e-275 Sponsors:   GlaxoSmithKline;   Click-TB Consortium Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 19, 2022 Category: Research Source Type: clinical trials